or Try an Advanced Search...

    Oab Stocks List

    Symbol Grade Name % Change
    AXNX C Axonics Modulation Technologies, Inc. 0.21
    URGN F UroGen Pharma Ltd. 1.95
    CNMD F CONMED Corporation 5.26
    ATRC F AtriCure, Inc. 1.08
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Medicine Clinical Medicine Minimally Invasive Procedure Ablation Antineoplastic Drugs Arrhythmia Arthroscopy Biopharmaceutical Bladder Cancer Botulinum Toxin Cancer Carcinoma Cardiac Arrhythmia Cardiac Monitoring Catheter Ablation Chemotherapy Coagulation Coagulation System Cryoablation Defibrillation

    Related ETFs - A few ETFs which own one or more of the above listed Oab stocks.

    Symbol Grade Name Weight
    IBRN D iShares Neuroscience and Healthcare ETF 4.67
    XHE D SPDR S&P Health Care Equipment 4.2
    MARB F First Trust Merger Arbitrage ETF 4.03
    ARB C AltShares Merger Arbitrage ETF 2.74
    MRGR B ProShares Merger ETF 2.54
    View all Oab ETFs...
    Compare ETFs
    Compare ARB to MRGR Compare IBRN to MARB Compare XHE to ARB

        Oab Stocks Recent News

        Date Stock Title
        Apr 25 CNMD Conmed Corp (CNMD) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Insights
        Apr 25 CNMD CONMED Corporation 2024 Q1 - Results - Earnings Call Presentation
        Apr 25 CNMD CONMED Corporation (CNMD) Q1 2024 Earnings Call Transcript
        Apr 24 CNMD Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say
        Apr 24 CNMD Conmed Corp (CNMD) Q1 2024 Earnings: Surpasses Revenue Estimates, Aligns with EPS Projections
        Apr 24 CNMD Conmed (CNMD) Surpasses Q1 Earnings and Revenue Estimates
        Apr 24 CNMD CONMED Non-GAAP EPS of $0.79 beats by $0.05, revenue of $312.3M beats by $5.58M
        Apr 24 CNMD CONMED promotes Patrick Beyer to chief operating officer
        Apr 24 CNMD CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
        Apr 24 CNMD CONMED Corporation Announces First Quarter 2024 Financial Results
        Apr 24 AXNX Boston Scientific Announces Results for First Quarter 2024
        Apr 23 CNMD CONMED Q1 2024 Earnings Preview
        Apr 22 URGN Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
        Related Industries: Biotechnology Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Medicine Clinical Medicine Minimally Invasive Procedure Ablation Antineoplastic Drugs Arrhythmia Arthroscopy Biopharmaceutical Bladder Cancer Botulinum Toxin Cancer Carcinoma Cardiac Arrhythmia Cardiac Monitoring Catheter Ablation Chemotherapy Coagulation Coagulation System Cryoablation Defibrillation
        Oab

        Browse All Tags